Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022

Same author

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022

Same author

Factors affecting the repeatability of gamma camera calibration for quantitative imaging applications using a sealed source.

Physics in medicine and biology·2015

Same author

Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer.

Practical radiation oncology·2014

Same author

EQPlanar: a maximum-likelihood method for accurate organ activity estimation from whole body planar projections.

Physics in medicine and biology·2011

Same author

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2009

Same journal

When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Same journal

Evaluation of audiovisual and auditory interventions on exam anxiety during whole-body magnetic resonance imaging in cancer patients: a quasi-experimental study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Same journal

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Same journal

Correction to: [¹⁸F]PSMA-1007 and [¹⁸F]FDG PET/CT in patients with metastatic triple-negative breast cancer: a prospective head-to-head comparison and assessment of PSMA-targeted radioligand therapy applicability.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Same journal

MRI-based perfusion-diffusion habitat analysis for characterizing intratumoral heterogeneity in rectal adenocarcinoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Same journal

Survival prediction of <sup>18</sup>F-FDG PET/CT in pediatric patients with recurrent neuroblastoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Molecular imaging in thyroid cancer.

T F Heston¹, R L Wahl

¹Department of Radiology, Johns Hopkins Nuclear Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA. theston1@jhmi.edu

Cancer Imaging : the Official Publication of the International Cancer Imaging Society

|February 18, 2010

Summary

This summary is machine-generated.

Molecular imaging, including radioiodine and FDG PET scans, aids thyroid cancer evaluation and treatment. These techniques help diagnose nodules, manage cancer recurrence, and guide therapy for various thyroid cancer types.

More Related Videos

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Area of Science:

Nuclear medicine
Oncology
Diagnostic imaging

Background:

Molecular imaging is crucial for thyroid cancer management.
Routine thyroid scanning for all nodules is no longer standard practice.
Radioiodine imaging and FDG PET have specific roles in diagnosis and follow-up.

Purpose of the Study:

To review the current applications of molecular imaging in thyroid cancer.
To highlight the utility of radioiodine and FDG PET in different clinical scenarios.
To discuss emerging imaging tracers for rarer thyroid cancer types.

Main Methods:

Review of current literature on molecular imaging in thyroid cancer.
Discussion of radioiodine imaging for nodule work-up and post-surgical ablation.
Evaluation of [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in dedifferentiated and aggressive thyroid cancers.

Main Results:

Radioiodine imaging is useful for suspected functioning nodules and indeterminate biopsies.
FDG PET is valuable for dedifferentiated cancers, elevated thyroglobulin with negative radioiodine scans, and unknown primaries.
Various tracers like 99mTc sestamibi and 124I show promise for specific thyroid cancer subtypes.

Conclusions:

Molecular imaging techniques, particularly radioiodine and FDG PET, are essential tools in thyroid cancer diagnosis, staging, and management.
The choice of imaging modality depends on the specific clinical context and thyroid cancer subtype.
Advancements in PET tracers offer expanding possibilities for comprehensive thyroid cancer imaging.